Ipilimumab vs Rosuvastatin

## Ipilimumab vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Rosuvastatin**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Rosuvastatin**: Competitive inhibitor of HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Rosuvastatin — 19 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Rosuvastatin — C22H28FN3O6S.

**Molecular Weight**: Ipilimumab — N/A; Rosuvastatin — 481.5390 g/mol.

**Type**: Ipilimumab — Antibody; Rosuvastatin — Small molecule.